{"title":"H-type of arterial hypertension: connection with atherosclerosis of carotid arteries","authors":"O. Rekovets, Y. Sirenko, O. Torbas, S. Kushnir","doi":"10.31928/2664-4479-2022.3-4.2229","DOIUrl":null,"url":null,"abstract":"The aim – determination of the relationship between arterial hypertension (AH) and hyperhomocysteinemia (H-Hcy) with the presence of atherosclerotic plaques in the carotid arteries.Materials and methods. Our research was carried out within the framework of the study HIPSTER in Ukraine. The study included 40 patients with I and II degrees of hypertension (average office systolic (SBP) / diastolic (DBP) BP – 155.88/92.60±1.63/1.43 mm Hg). The average age of the patients was 55.85±2.09 years. Patients with homocystein level ≥ 10 μmol/L were defined as patients with H-Hcy (H-type AH). The stiffness of blood vessels was determined by PWV. Patients were examined at the beginning, after 6 months of treatment. Determination of the presence of atherosclerosis of the carotid arteries was detected at the beginning and after 12 months.Results and discussion. We found that office blood pressure in patients with H-type hypertension at the beginning and after 6 months of treatment was higher compared to patients without hypertension (156.45±1.04 mm Hg vs. 152.55±1.41 mm Hg at the beginning (p<0.05) and 130.65±0.96 mm Hg versus 126.97±1.08 mm Hg after 6 months (p<0,05)). Patients with H-type AH compared to patients without H-Hcy had a more insulin resistance (HOMA index 4.27±0.18 vs. 3.20±0.24 units, p<0.05). Atherosclerotic plaques in carotid arteries were found in 56.7 % (n=17) of patients with H-type hypertension and in 40.0 % (n=4) of patients with hypertension without H-Hcy (p<0.05 between groups). Patients with H-type AH had a higher prevalence of carotid atherosclerosis – atherosclerotic plaque area measured by NASCET was 43.4 % vs. 26.7 %, p<0.05, and was greater than in patients with AH without H-Hcy. 3 patients (10.0 %) with H-type AH developed new atherosclerotic plaques after 12 months, and no patients from the AH group without H-Hcy. After regression analysis, homocysteine was associated with PWV regardless of the reduction of blood pressure on the therapy, as well as with the level of LDL cholesterol and the presence of atherosclerotic plaques in the carotid arteries. Homocysteine was associated with PWVel after treatment (β=0.307, р=0.001), LDL cholesterol level before treatment (β=–1.501, р=0.017), and the presence of atherosclerotic of plaques in carotid arteries after treatment (β=5.236, р=0.031).Conclusions. H-type of arterial hypertension was associated with the presence of atherosclerotic plaques of the carotid arteries.","PeriodicalId":23419,"journal":{"name":"Ukrainian Journal of Cardiology","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ukrainian Journal of Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31928/2664-4479-2022.3-4.2229","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The aim – determination of the relationship between arterial hypertension (AH) and hyperhomocysteinemia (H-Hcy) with the presence of atherosclerotic plaques in the carotid arteries.Materials and methods. Our research was carried out within the framework of the study HIPSTER in Ukraine. The study included 40 patients with I and II degrees of hypertension (average office systolic (SBP) / diastolic (DBP) BP – 155.88/92.60±1.63/1.43 mm Hg). The average age of the patients was 55.85±2.09 years. Patients with homocystein level ≥ 10 μmol/L were defined as patients with H-Hcy (H-type AH). The stiffness of blood vessels was determined by PWV. Patients were examined at the beginning, after 6 months of treatment. Determination of the presence of atherosclerosis of the carotid arteries was detected at the beginning and after 12 months.Results and discussion. We found that office blood pressure in patients with H-type hypertension at the beginning and after 6 months of treatment was higher compared to patients without hypertension (156.45±1.04 mm Hg vs. 152.55±1.41 mm Hg at the beginning (p<0.05) and 130.65±0.96 mm Hg versus 126.97±1.08 mm Hg after 6 months (p<0,05)). Patients with H-type AH compared to patients without H-Hcy had a more insulin resistance (HOMA index 4.27±0.18 vs. 3.20±0.24 units, p<0.05). Atherosclerotic plaques in carotid arteries were found in 56.7 % (n=17) of patients with H-type hypertension and in 40.0 % (n=4) of patients with hypertension without H-Hcy (p<0.05 between groups). Patients with H-type AH had a higher prevalence of carotid atherosclerosis – atherosclerotic plaque area measured by NASCET was 43.4 % vs. 26.7 %, p<0.05, and was greater than in patients with AH without H-Hcy. 3 patients (10.0 %) with H-type AH developed new atherosclerotic plaques after 12 months, and no patients from the AH group without H-Hcy. After regression analysis, homocysteine was associated with PWV regardless of the reduction of blood pressure on the therapy, as well as with the level of LDL cholesterol and the presence of atherosclerotic plaques in the carotid arteries. Homocysteine was associated with PWVel after treatment (β=0.307, р=0.001), LDL cholesterol level before treatment (β=–1.501, р=0.017), and the presence of atherosclerotic of plaques in carotid arteries after treatment (β=5.236, р=0.031).Conclusions. H-type of arterial hypertension was associated with the presence of atherosclerotic plaques of the carotid arteries.
目的-确定动脉高血压(AH)和高同型半胱氨酸血症(H-Hcy)与颈动脉粥样硬化斑块之间的关系。材料和方法。我们的研究是在乌克兰HIPSTER研究的框架内进行的。该研究纳入了40例I和II级高血压患者(平均收缩压/舒张压- 155.88/92.60±1.63/1.43 mm Hg)。患者平均年龄55.85±2.09岁。同型半胱氨酸水平≥10 μmol/L定义为H-Hcy (h型AH)。采用PWV法测定血管刚度。患者在治疗6个月后开始接受检查。在开始和12个月后检测颈动脉粥样硬化的存在。结果和讨论。我们发现h型高血压患者治疗开始时和治疗6个月后的办公室血压高于无高血压患者(156.45±1.04 mm Hg比152.55±1.41 mm Hg (p<0.05), 6个月后130.65±0.96 mm Hg比126.97±1.08 mm Hg (p<0.05))。h型AH患者胰岛素抵抗高于非h型AH患者(HOMA指数4.27±0.18比3.20±0.24,p<0.05)。h型高血压患者颈动脉粥样硬化斑块发生率为56.7% (n=17),非H-Hcy型高血压患者颈动脉粥样硬化斑块发生率为40.0% (n=4)(组间p<0.05)。h型AH患者颈动脉粥样硬化的患病率更高——NASCET测量的动脉粥样硬化斑块面积为43.4%比26.7%,p<0.05,高于无H-Hcy的AH患者。3例(10.0%)h型AH患者在12个月后出现新的动脉粥样硬化斑块,无H-Hcy的AH组无患者。经过回归分析,同型半胱氨酸与PWV相关,与治疗后血压的降低无关,也与LDL胆固醇水平和颈动脉粥样硬化斑块的存在有关。同型半胱氨酸与治疗后PWVel (β=0.307, r =0.001)、治疗前LDL胆固醇水平(β= -1.501, r =0.017)、治疗后颈动脉粥样硬化斑块的存在相关(β=5.236, r =0.031)。h型动脉高血压与颈动脉粥样硬化斑块的存在有关。